Chrysler recalls 265,512 vehicles over steering risk, raising UAE clinic and insurer exposure

Chrysler (FCA US, LLC) has recalled 265,512 Ram ProMaster vehicles in the United States after a steering defect that can disable power steering assist, according to National Highway Traffic Safety Administration campaign 26V621000.

The affected vehicles are 2022-2026 Ram 1500 ProMaster, 2022-2026 Ram 2500 ProMaster, 2022-2026 Ram 3500 ProMaster and 2024-2026 Ram 3500 Electric models. The recall is outside the UAE, but the operational risk is local for any Dubai clinic, home-care company, pharmacy logistics provider or insurer using imported vans, leased fleets or grey-market vehicles. Dubai operators fall under Dubai Health Authority (DHA) licensing, Abu Dhabi and Al Ain operators under Department of Health Abu Dhabi (DOH), and northern emirates operators under Ministry of Health and Prevention (MOHAP) oversight.

What the recall says

NHTSA’s recall summary says water may enter the electric power steering wiring harness, which can disable power steering assist. NHTSA states that loss of power steering assist can increase crash risk. Vehicle identification numbers linked to the campaign became searchable on 6 October 2026. Interim owner notification letters were expected from 8 October 2026, while the final repair timetable should be checked through Chrysler, Ram or NHTSA by VIN.

For UAE healthcare operators, the immediate task is a fleet check rather than a clinical protocol. The highest-risk users are providers with repeated daily trips: home nursing teams, medicine delivery fleets, sample collection couriers and patient transport contractors. A steering-assist failure on Sheikh Zayed Road, Al Khail Road, E11 or E311 would create a patient-safety and claims issue before it becomes a procurement issue.

• Fleet teams should run VIN checks for any Ram ProMaster or imported Chrysler commercial vehicle used after 2022.
• COOs should ask leasing vendors for written recall status before assigning vehicles to patient-facing routes.
• Insurers, including Daman, Thiqa and Sukoon where policy terms apply, should expect accident-related pre-authorisation and physiotherapy queries after any fleet incident.
• Pharmacy managers should check whether medicine delivery vans are owned, leased or outsourced, then document the responsible party for recall compliance.

Why clinics and pharmacies should care

The recall is a vehicle-safety notice, but the UAE healthcare impact sits in three places: accident triage, claims documentation and medicine delivery continuity. A clinic that treats a driver or passenger after a steering-related crash may need to document mechanism of injury, vehicle type, date and police report reference. That record can affect motor insurance, health insurance and employer liability processes.

For pharmacies, the concern is service continuity. A delivery vehicle taken off the road can disrupt same-day medicine supply, especially for chronic medicines, temperature-sensitive items and post-discharge prescriptions. UAE pharmacies should avoid advising patients to stockpile medicines without a clinician’s instruction. For controlled, semi-controlled or prescription-only medicines, dispensing remains subject to UAE rules and the pharmacy’s regulator: DHA in Dubai, DOH in Abu Dhabi and Al Ain, and MOHAP in the northern emirates.

Patients asking about pain relief after a minor road incident should be referred through normal clinical pathways. Pharmacy teams can advise on labelled use for over-the-counter products, but red-flag symptoms after a crash, including chest pain, neurological symptoms, severe headache, loss of consciousness or worsening neck pain, need medical assessment. Providers should give patients a written estimate before dispensing or treatment where insurance coverage is unclear; prices vary by brand, dosage, facility and insurer network, so UAE operators should check the live pharmacy price or insurer portal instead of relying on a generic range.

What UAE operators should do this week

Dubai operators should start with a written inventory: vehicle make, model year, VIN, lease owner, daily route and clinical purpose. The same file should be held for Abu Dhabi, Al Ain and northern emirates operations. If a vehicle is outsourced, the healthcare provider should request recall evidence from the logistics contractor, because service continuity still sits with the licensed provider in front of the patient.

CFOs should treat the recall as a contingent cost item. The repair may be free in the recall market, but local downtime, replacement vans, missed deliveries and rejected claims are local costs. COOs should create a temporary route plan for affected vehicles before a failure occurs. CIOs should add a recall-status field to fleet or vendor-management records if the organisation already tracks vehicle documents digitally.

The next signal to watch is whether Stellantis, Chrysler, Ram dealers or UAE consumer-safety channels publish a local campaign for imported ProMaster units. Until then, operators should use the VIN tool, keep vendor responses on file and avoid assigning unverified vehicles to patient transport or pharmacy delivery routes. For licensed pharmacy providers in Dubai, Abu Dhabi and the northern emirates, readers can cross-check provider options through the UAE Open Healthcare Directory.